[Hachioji City, Tokyo] "Metallo-Balance Test" to assess cancer and cognitive decline risk with just 6mL of blood, to be offered at Clinic Tajima (Iroha Medical Corporation) from September 2026 <Reservations now open>

Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), which builds health indicators based on trace elements and applies them in real-world settings, is pleased to announce that the screening test "Metallo-Balance Test," developed and provided by the company to assess the risk of cancer and MCI (Mild Cognitive Impairment), will newly commence on September 15, 2026 (Tue) at Clinic Tajima (Hachioji City, Tokyo), operated by Iroha Medical Corporation.

With the addition of this clinic, the availability of the "Metallo-Balance Test" in the Hachioji City, Tokyo area and its surroundings will be further expanded, offering a more accessible and new health management option to local residents.

Our company will continue to partner with medical institutions nationwide to encourage more people to take an interest in their health status and provide an opportunity to review their daily health management and lifestyle habits as a measure against pre-illness.

What is the Metallo-Balance (MB) Test?

This is a risk screening (sorting) test that objectively assesses the risk of cancer and MCI (Mild Cognitive Impairment) at the time of blood collection by analyzing the concentration balance of 17 types of trace elements (metal elements) in the blood.

【Features of this test】

Just one 6mL blood draw: Blood is collected safely under the appropriate management system of the medical institution. The test takes approximately 15 minutes, a short time, with minimal burden on the body, ensuring peace of mind.

"Cancer Risk Test" by site: With a single blood draw, the risk of the following cancers is assessed by site (6 sites for men, 9 sites for women) and scored on a 4-point scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, uterine body cancer, ovarian cancer

Comprehensive "Cognitive Risk Test (MCI Risk Assessment)": This test comprehensively assesses all types of cognitive decline, not only Alzheimer's type but also vascular dementia, Lewy body dementia, and others.

Proven research results and international recognition: Developed with research grants from the Ministry of Economy, Trade and Industry's Go-Tech project and in joint research with Kanagawa Cancer Center and Chiba Cancer Center. Patents have been obtained in 9 countries worldwide, including Japan, and the cumulative number of examinees has surpassed 100,000 (actual results from April 2019 to March 2026).

Examination flow and main precautions before examination

*Due to the need for mail processing of documents, advance application is required approximately 3 weeks before the desired examination date (reservation system only).

Application: Please apply via the web or by phone. Approximately one week before your reservation date, a complete set of examination documents will be sent to your home.

Day of examination (blood collection): As this is a reservation-only system, blood collection will proceed smoothly (approx. 15 minutes). Payment is made after the examination, so no payment is required at the counter on the day.

Notification of results: The invoice (payment slip) will be mailed to your home approximately 3 weeks after blood collection, and the test results approximately 5 weeks later.

【Main precautions before examination】

Food and drink: No food or drink after 9:00 PM the day before. No alcohol from the day before. Water: Please drink plenty of water to facilitate blood collection.

Medications/Supplements: Over-the-counter medications and supplements are not allowed from the day before. Prescription medications should be taken as usual.

Examination Fee (Out-of-pocket medical expenses)

This test is not covered by health insurance and is subject to out-of-pocket medical expenses. You can choose from the following courses according to your needs.

Cancer Risk Test: ¥19,800 (tax included)

Cognitive Risk Test: ¥19,800 (tax included)

Cancer and Cognitive Risk Test Set: ¥24,200 (tax included)

*Prices shown are standard prices. *Payment will be made via "DSK Post-Payment" delivered to your home after blood collection. *Some medical institutions may not offer one of these tests.

Target individuals for the Metallo-Balance Test and precautions

【Regarding target age】

Cancer Risk Test: Japanese individuals aged 20 to 80

Cognitive Risk Test: Japanese individuals aged 50 to 80

*This test was developed based on data from Japanese individuals within the above age ranges. Therefore, while individuals outside these age ranges or foreign nationals can take the test, the results will be considered "reference values" only. Please be aware of this in advance.

【The following individuals cannot take the test】

Individuals who are pregnant or within 6 months postpartum.

Individuals undergoing cancer treatment or who have completed cancer treatment less than 1 year ago.

Individuals undergoing dialysis.

Individuals with bone fractures, blood disorders, or immunodeficiency (excluding dyslipidemia due to high triglycerides, etc.).

Individuals who are unwell (e.g., due to lack of sleep, after staying up all night, immediately after strenuous exercise, under severe stress, or if experiencing symptoms such as a cold, asthma, shingles, allergic rash, or rhinitis).

Overview of New Introducing Medical Institution

Test start date: September 15, 2026 (Tue) Test hours: Generally every Monday, Tuesday, Wednesday, and Friday (excluding holidays and public holidays)

Medical Institution Name: Clinic Tajima (Iroha Medical Corporation)

Address: 3-2263-5 Motohachiojimachi, Hachioji City, Tokyo 193-0826 🅿️Parking available 📍MAP

Access: 3-minute walk from "Kajiyashiki" bus stop from Takao Station / 10-minute drive from Nishi-Hachioji Station

Tests offered: Cancer Risk Test, Cognitive Risk Test

⚠️ Important request regarding examination (Please read carefully) Please refrain from contacting the medical institution directly: The hospital counter and phone lines cannot handle inquiries or applications for this test. For questions or applications regarding the test, please contact Renatech.

For details and to apply for the test, click here.

Metallo-Balance Test Information Site: https://www.mbkensa.com/

Dedicated Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00 AM - 5:00 PM)

▼ Digital version of the Metallo-Balance Test leaflet

d182526-16-ecb5fa5aecbf069dd612ea83268134f1.pdf

🏥 We are also recruiting partner medical institutions nationwide! For information on introducing the Metallo-Balance Test, click here.

Metallo-Balance Original Character: Metalona-chan

Renatech Inc. is an innovation company that develops unique technologies in the medical, health, and environmental fields, aiming for early risk assessment of diseases such as cancer. The company has also been selected as one of the "300 Brilliant Companies" by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing outstanding companies that develop innovative technologies and provide services, acknowledging its high technological capabilities and social contributions at the national level.

Among these, the "Metallo-Balance Test" is attracting significant attention as a groundbreaking screening technology that assesses the risk of developing cancer and MCI (Mild Cognitive Impairment) by analyzing the concentration of 17 types of trace elements in the blood. Moving forward, based on its advanced technological capabilities, the company will continue to create new value for the promotion of people's health and the resolution of social issues.

Company Profile ■

Company Name: Renatech Inc.

Representative: Kei Kato, President and Representative Director

Head Office Location: 4-19-15 Takamori, Isehara City, Kanagawa Prefecture 259-1114

URL: https://www.renatech.net/